Latest filing published 11 Mar 2026 for Natco Pharma Limited, €664k.
Filing timeline
BuySaleSanjay Nannapaneni: trading record in brief
All filings by Sanjay Nannapaneni on record concern Natco Pharma Limited. Over a trading history stretching from 28 February 2025 to 9 March 2026, the count stands at 4 filings.
No open-market purchase appears, only 2 sales worth €1.4M. 2026 to date brings no purchases and 1 sale.
Most recently, on 11 March 2026, the filings show an open-market sale worth €664k in Natco Pharma Limited. Between a trade and the moment it shows up on SEBI (PIT + SAST), the median delay is 2 days. The shorter that gap, the sooner other investors can see what insiders have done. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEBI (PIT + SAST) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Sanjay Nannapaneni
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 70,000 shares@ ₹1,017.30530.0005% mcap46.3% of flowEquity SharesSEBI:274dc5941df2918e536d89fc2bfcd269e582cd13
- 100,000 shares@ ₹803.052153.7% of flowEquity SharesSEBI:b08d1b8e9605bade4516a11dd1e0d4ec399a5bbf
- 286,910 sharesEquity SharesSEBI:086f24f983a07e21aa405ad1dc4c722a752cf11eCanonical exit: 24 Jun 2025 (T+90)
- 40,000 sharesEquity SharesSEBI:8a74d3cf1b8972d8512eed280c6425f499a76eecCanonical exit: 29 May 2025 (T+90)
4 of 4 declarations